← Nazad


Gatta G



Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202-e17. [Šekerija M]

Autori: Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC
Godina: 2017

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A, RARECAREnet working group
Godina: 2017

Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer. 2017;82:137-48. [Šekerija M]

Autori: Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sanchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L, EUROCARE-5 Working Group
Godina: 2017

Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30685-6. doi: 10.1016/j.ejso.2017.08.018. [Epub ahead of print] [Šekerija M]

Autori: Gatta G, Trama A, Capocaccia R, RARECAREnet working group
Godina: 2017

(Šekerija M) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. European Journal of Cancer. 2015.

Autori: Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L
Godina: 2015